Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Corbus Pharmaceuticals Holdings, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
CRBP
Nasdaq
2830
www.corbuspharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals to Present at the Guggenheim SMID Cap Biotech Conference
- Jan 28th, 2025 1:00 pm
Corbus Pharmaceuticals Announces that Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at ASCO GU 2025
- Jan 8th, 2025 1:00 pm
Corbus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- Jan 6th, 2025 1:00 pm
Corbus Pharmaceuticals Announces Dosing of First Patient in its First-In-Human Study of CRB-601 to Treat Patients with Advanced Solid Tumors
- Dec 9th, 2024 12:00 pm
Why Is Corbus Pharmaceuticals Holdings, Inc. (CRBP) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds?
- Dec 4th, 2024 5:31 pm
FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer
- Dec 3rd, 2024 12:00 pm
Corbus Pharmaceuticals Holdings, Inc. (CRBP): An Oversold Healthcare Stock to Invest In Now
- Nov 26th, 2024 11:54 am
Corbus Pharmaceuticals to Present at the 7th Annual Evercore HealthCONx Conference
- Nov 21st, 2024 1:00 pm
Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference
- Nov 12th, 2024 1:00 pm
We're Not Very Worried About Corbus Pharmaceuticals Holdings' (NASDAQ:CRBP) Cash Burn Rate
- Nov 9th, 2024 2:39 pm
Corbus Pharmaceuticals: Q3 Earnings Snapshot
- Nov 7th, 2024 12:28 pm
Corbus Pharmaceuticals Reports 3rd Quarter 2024 Financial Results and Provides a Corporate Update
- Nov 7th, 2024 12:00 pm
Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat
- Nov 4th, 2024 9:10 pm
Corbus Pharmaceuticals Presents New CRB-913 Pre-Clinical Data At Obesity Week 2024
- Nov 4th, 2024 12:00 pm
Corbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation Conference
- Oct 29th, 2024 12:00 pm
Corbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC (CRB-701)
- Oct 16th, 2024 12:00 pm
Is Corbus Pharmaceuticals Holdings, Inc. (CRBP) the Best Russell 2000 Stock to Buy According to Analysts?
- Oct 3rd, 2024 9:07 am
Corbus Pharmaceuticals to Participate in the BMO Capital Markets’ Oncology Summit
- Sep 26th, 2024 12:00 pm
Cormorant Asset Management's Strategic Acquisition in Corbus Pharmaceuticals
- Sep 25th, 2024 1:41 am
Novo Nordisk's Monlunabant Data Drags Stocks Of Smaller Players
- Sep 20th, 2024 7:18 pm
Scroll